268 related articles for article (PubMed ID: 30120199)
1. Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43).
Hans F; Eckert M; von Zweydorf F; Gloeckner CJ; Kahle PJ
J Biol Chem; 2018 Oct; 293(41):16083-16099. PubMed ID: 30120199
[TBL] [Abstract][Full Text] [Related]
2. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.
Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV
J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288
[TBL] [Abstract][Full Text] [Related]
3. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
[TBL] [Abstract][Full Text] [Related]
4. Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules.
Hans F; Glasebach H; Kahle PJ
J Biol Chem; 2020 Jan; 295(3):673-689. PubMed ID: 31780563
[TBL] [Abstract][Full Text] [Related]
5. UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination.
Hans F; Fiesel FC; Strong JC; Jäckel S; Rasse TM; Geisler S; Springer W; Schulz JB; Voigt A; Kahle PJ
J Biol Chem; 2014 Jul; 289(27):19164-79. PubMed ID: 24825905
[TBL] [Abstract][Full Text] [Related]
6. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
[TBL] [Abstract][Full Text] [Related]
7. RNP2 of RNA recognition motif 1 plays a central role in the aberrant modification of TDP-43.
Takagi S; Iguchi Y; Katsuno M; Ishigaki S; Ikenaka K; Fujioka Y; Honda D; Niwa J; Tanaka F; Watanabe H; Adachi H; Sobue G
PLoS One; 2013; 8(6):e66966. PubMed ID: 23840565
[TBL] [Abstract][Full Text] [Related]
8. [Neurodegenerative disorders and TDP-43].
Nonaka T; Inukai Y; Arai T; Hasegawa M
Brain Nerve; 2009 Feb; 61(2):161-6. PubMed ID: 19235466
[TBL] [Abstract][Full Text] [Related]
9. The amyloidogenicity of a C-terminal region of TDP-43 implicated in Amyotrophic Lateral Sclerosis can be affected by anions, acetylation and homodimerization.
Prasad A; Sivalingam V; Bharathi V; Girdhar A; Patel BK
Biochimie; 2018 Jul; 150():76-87. PubMed ID: 29751083
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43.
Garcia Morato J; Hans F; von Zweydorf F; Feederle R; Elsässer SJ; Skodras AA; Gloeckner CJ; Buratti E; Neumann M; Kahle PJ
Nat Commun; 2022 Mar; 13(1):1223. PubMed ID: 35264561
[TBL] [Abstract][Full Text] [Related]
11. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing.
Che MX; Jiang YJ; Xie YY; Jiang LL; Hu HY
FASEB J; 2011 Jul; 25(7):2344-53. PubMed ID: 21450909
[TBL] [Abstract][Full Text] [Related]
12. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
14. Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function.
Li W; Reeb AN; Lin B; Subramanian P; Fey EE; Knoverek CR; French RL; Bigio EH; Ayala YM
J Biol Chem; 2017 Mar; 292(12):5089-5100. PubMed ID: 28167528
[TBL] [Abstract][Full Text] [Related]
15. TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues.
Li HR; Chiang WC; Chou PC; Wang WJ; Huang JR
J Biol Chem; 2018 Apr; 293(16):6090-6098. PubMed ID: 29511089
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution.
Maraschi A; Gumina V; Dragotto J; Colombrita C; Mompeán M; Buratti E; Silani V; Feligioni M; Ratti A
Mol Neurobiol; 2021 Nov; 58(11):5682-5702. PubMed ID: 34390468
[TBL] [Abstract][Full Text] [Related]
17. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
Prudlo J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
[TBL] [Abstract][Full Text] [Related]
18. [TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].
Hasegawa M; Nonaka T; Yamashita M; Kametani F; Arai T; Yoshida M; Hashizume Y; Tsuchiya K; Akiyama H
Rinsho Shinkeigaku; 2009 Nov; 49(11):783-5. PubMed ID: 20030209
[TBL] [Abstract][Full Text] [Related]
19. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation.
Winton MJ; Igaz LM; Wong MM; Kwong LK; Trojanowski JQ; Lee VM
J Biol Chem; 2008 May; 283(19):13302-9. PubMed ID: 18305110
[TBL] [Abstract][Full Text] [Related]
20. Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site.
Furukawa Y; Kaneko K; Nukina N
Biochim Biophys Acta; 2011 Dec; 1812(12):1577-83. PubMed ID: 21946215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
